The role of MTHFR in menopause is not a well-established clinical concept but rather an area driven by mechanistic hypotheses and small association studies. MTHFR encodes a key enzyme in folate and homocysteine metabolism. Certain variants (especially C677T and A1298C) can reduce enzyme activity and elevate homocysteine levels. Elevated homocysteine is linked to cardiovascular risk, bone density loss, and possibly vasomotor symptoms (hot flashes)—all relevant during menopause. However, evidence for a direct causal role of MTHFR on menopause timing or symptom severity is weak and inconsistent. Most studies are small, unreplicated, or show only modest effect sizes. Moreover, many other genes and environmental factors contribute. A genetic test for MTHFR cannot guide clinical decisions about menopause. It only offers a hint about possible metabolic peculiarities that should be considered in the broader context of diet and lifestyle. Measuring blood homocysteine is more informative than genotype alone. In summary: MTHFR has a plausible but unproven role in menopause; the utility of home tests is limited.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-89995f0b81ab026e73564a66